These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19807804)

  • 41. Progression-free survival remains debatable endpoint in cancer trials.
    Tuma R
    J Natl Cancer Inst; 2009 Nov; 101(21):1439-41. PubMed ID: 19828873
    [No Abstract]   [Full Text] [Related]  

  • 42. Tonic and atonic seizures: what's next--VNS or callosotomy?
    Rosenfeld WE; Roberts DW
    Epilepsia; 2009 Sep; 50 Suppl 8():25-30. PubMed ID: 19702730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Minimizing and accounting for the impact of rescue therapies in clinical trials.
    Fergusson DA; Ramsay T
    Pediatr Crit Care Med; 2009 Jul; 10(4):524-5. PubMed ID: 19584638
    [No Abstract]   [Full Text] [Related]  

  • 44. Patients' understanding of randomised controlled trials depends on their education.
    Pucci E; Belardinelli N; Signorino M; Angeleri F
    BMJ; 1999 Mar; 318(7187):875. PubMed ID: 10092281
    [No Abstract]   [Full Text] [Related]  

  • 45. Adverse events in randomized trials: neglected, restricted, distorted, and silenced.
    Ioannidis JP
    Arch Intern Med; 2009 Oct; 169(19):1737-9. PubMed ID: 19858427
    [No Abstract]   [Full Text] [Related]  

  • 46. 12th international conference on Alzheimer's disease. Part 1. 11-16 July 2009, Vienna, Austria.
    Filson S
    IDrugs; 2009 Sep; 12(9):535-6. PubMed ID: 19697267
    [No Abstract]   [Full Text] [Related]  

  • 47. Why internal and external validity of experimental studies are relevant for clinical practice?
    Cipriani A; Purgato M; Barbui C
    Epidemiol Psichiatr Soc; 2009; 18(2):101-3. PubMed ID: 19526740
    [No Abstract]   [Full Text] [Related]  

  • 48. Alzheimer's biomarker initiative hits its stride.
    Miller G
    Science; 2009 Oct; 326(5951):386-9. PubMed ID: 19833956
    [No Abstract]   [Full Text] [Related]  

  • 49. MRI as an outcome in multiple sclerosis clinical trials.
    Sormani MP; Filippi M; De Stefano N; ; Ebers G; Daumer M
    Neurology; 2009 Dec; 73(22):1932; author reply 1932-3. PubMed ID: 19949043
    [No Abstract]   [Full Text] [Related]  

  • 50. [Reevaluation of four medications indicated by the French authority in Alzheimer disease].
    Capelle V
    Soins Gerontol; 2007; (68):5. PubMed ID: 18179028
    [No Abstract]   [Full Text] [Related]  

  • 51. Are onsite image evaluations the solution or are we trading one problem for another?
    Raunig DL
    J Clin Oncol; 2009 Dec; 27(35):e263-4; author reply e265. PubMed ID: 19901131
    [No Abstract]   [Full Text] [Related]  

  • 52. Rivastigmine patches: line extension. No therapeutic advantage and less convenient than capsules.
    Prescrire Int; 2009 Feb; 18(99):19. PubMed ID: 19391277
    [No Abstract]   [Full Text] [Related]  

  • 53. JAMA strikes again!
    Head K
    Altern Med Rev; 2007 Mar; 12(1):1-3. PubMed ID: 19760821
    [No Abstract]   [Full Text] [Related]  

  • 54. Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials.
    Soares CN; Kornstein SG; Thase ME; Jiang Q; Guico-Pabia CJ
    J Clin Psychiatry; 2009 Oct; 70(10):1365-71. PubMed ID: 19906341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emergence of large treatment effects from small trials.
    Batterham AM; Hopkins WG
    JAMA; 2013 Feb; 309(8):768. PubMed ID: 23443434
    [No Abstract]   [Full Text] [Related]  

  • 56. Emergence of large treatment effects from small trials--reply.
    Ioannidis JP; Pereira TV; Horwitz RI
    JAMA; 2013 Feb; 309(8):768-9. PubMed ID: 23443435
    [No Abstract]   [Full Text] [Related]  

  • 57. Identifying difficult-to-treat depression: differential diagnosis, subtypes, and comorbidities.
    Gaynes BN
    J Clin Psychiatry; 2009; 70 Suppl 6():10-5. PubMed ID: 19922739
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comment on the debate surrounding single- and multifactorial falls prevention interventions.
    Russell MA; Hill KD; Haines TP
    J Am Geriatr Soc; 2009 Sep; 57(9):1708-9. PubMed ID: 19895434
    [No Abstract]   [Full Text] [Related]  

  • 59. Improving the health of patients and populations requires humility, uncertainty, and collaboration.
    Oxman AD
    JAMA; 2012 Oct; 308(16):1691-2. PubMed ID: 23093168
    [No Abstract]   [Full Text] [Related]  

  • 60. [Final report is now available. IQWiG doubts the effectiveness of memantine].
    MMW Fortschr Med; 2009 Sep; 151(39):6. PubMed ID: 19831181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.